# Keros Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Oct 16, 2025

- Company: [Keros Therapeutics, Inc.](/companies/kros.md) (CIK 1664710)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-16
- Accepted by EDGAR: Oct 16, 2025, 17:36 ET
- Period: not reported
- Accession: 0000921895-25-002751
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1664710/000092189525002751/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1664710/000092189525002751/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1664710/000092189525002751/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 16, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-002751. Last ingested by Listed: Nov 5, 2026, 17:32 ET. No prices; not investment advice.